Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Holistic treatments like diet, exercise, and mental well-being should be prioritized for better PCOS management.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Mitochondrial dysfunction links metabolic syndrome and inflammatory skin diseases, suggesting targeted therapies and lifestyle changes.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Metabolic syndrome may worsen certain skin conditions, and managing both together is important.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Women with PCOS have a higher risk of heart disease.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.